on this page
Patient eligibility
The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with nitisinone under the National Health Act 1953, section 100 for patients with HT-1.
Patients must be eligible for the PBS and meet the relevant restriction criteria.
The Schedule of Pharmaceutical Benefits on the PBS website outlines the restrictions for prescribing nitisinone.
Section 100 arrangements
Nitisinone
This item is only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending either:
- an approved private hospital
- a public hospital.
This item isn’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.
Treatment specifics
To be eligible for PBS-subsidised treatment with nitisinone, patients must be treated by a physician with expertise in the management of HT-1 in a centre with expertise in genetic metabolic disorders.
Authority applications
Please note: You’ll get an immediate assessment when you request PBS authorities online.
Applying for initial treatment
Applications for initial authority approval to prescribe PBS-subsidised nitisinone to treat HT-1 can be made in:
- real time using the Online PBS Authorities system
- writing and using HPOS Form upload
- writing and mailed to PBS Complex Drugs Programs.
All written applications must include:
- details of the proposed prescription or prescriptions
- the completed hereditary tyrosinaemia type 1 - nitisinone - initial authority application form.
Applying for initial grandfather treatment
Applications for initial grandfather authority approval to prescribe PBS-subsidised nitisinone to treat HT-1 can be made in:
- real time using the Online PBS Authorities system
- writing and using HPOS Form upload
- writing and mailed to PBS Complex Drugs Programs.
All written applications must include:
- details of the proposed prescription or prescriptions
- the completed hereditary tyrosinaemia type 1 - nitisinone - initial grandfather authority application form.
Applying for continuing treatment
Applications for continuing authority approval to prescribe PBS-subsidised nitisinone to treat HT-1 can be made either:
- in real time using the Online PBS Authorities system
- by calling the PBS Complex Drugs Programs enquiry line.
More information
Call the PBS Complex Drugs Programs enquiry line for more information.